Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions

The role of fluoroquinolones (FQs) as empirical therapy for community-acquired pneumonia (CAP) remains controversial in countries with high tuberculosis (TB) endemicity owing to the possibility of delayed TB diagnosis and treatment and the emergence of FQ resistance in Mycobacterium tuberculosis. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Gwan-Han, Tsao, Thomas Chang-Yao, Kao, Shang-Jyh, Lee, Jen-Jyh, Chen, Yen-Hsu, Hsieh, Wei-Chung, Hsu, Gwo-Jong, Hsu, Yen-Tao, Huang, Ching-Tai, Lau, Yeu-Jun, Tsao, Shih-Ming, Hsueh, Po-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and the International Society of Chemotherapy. 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127649/
https://www.ncbi.nlm.nih.gov/pubmed/22285045
http://dx.doi.org/10.1016/j.ijantimicag.2011.11.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127649/
https://www.ncbi.nlm.nih.gov/pubmed/22285045
http://dx.doi.org/10.1016/j.ijantimicag.2011.11.014

Ejemplares similares